应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
CMMB Chemomab Therapeutics Ltd.
休市中 06-28 16:00:00 EDT
0.9125
-0.0585
-6.02%
盘后
0.9100
-0.0025
-0.27%
16:43 EDT
最高
1.01
最低
0.9000
成交量
6.92万
今开
0.9700
昨收
0.9710
日振幅
11.33%
总市值
1,297万
流通市值
858.33万
总股本
1,422万
成交额
6.45万
换手率
0.74%
流通股本
940.64万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Chemomab Therapeutics Ltd盘中异动 快速上涨6.13%报1.060美元
自选股智能写手 · 06-26
Chemomab Therapeutics Ltd盘中异动 快速上涨6.13%报1.060美元
Chemomab Therapeutics Ltd盘中异动 快速拉升5.38%
自选股智能写手 · 06-25
Chemomab Therapeutics Ltd盘中异动 快速拉升5.38%
Chemomab Therapeutics Ltd盘中异动 早盘快速下挫5.06%
自选股智能写手 · 06-20
Chemomab Therapeutics Ltd盘中异动 早盘快速下挫5.06%
Chemomab Therapeutics Ltd盘中异动 快速拉升11.08%
自选股智能写手 · 06-18
Chemomab Therapeutics Ltd盘中异动 快速拉升11.08%
Chemomab Therapeutics Ltd盘中异动 早盘股价大跌5.31%
自选股智能写手 · 06-17
Chemomab Therapeutics Ltd盘中异动 早盘股价大跌5.31%
Chemomab Therapeutics Ltd盘中异动 股价大涨6.01%报1.060美元
自选股智能写手 · 06-12
Chemomab Therapeutics Ltd盘中异动 股价大涨6.01%报1.060美元
Chemomab Therapeutics Ltd盘中异动 股价大涨9.03%报1.090美元
自选股智能写手 · 06-12
Chemomab Therapeutics Ltd盘中异动 股价大涨9.03%报1.090美元
Chemomab Therapeutics Ltd盘中异动 早盘股价大跌6.13%报1.07美元
自选股智能写手 · 06-07
Chemomab Therapeutics Ltd盘中异动 早盘股价大跌6.13%报1.07美元
Chemomab Therapeutics Ltd盘中异动 早盘急速跳水6.20%报1.21美元
自选股智能写手 · 06-06
Chemomab Therapeutics Ltd盘中异动 早盘急速跳水6.20%报1.21美元
Chemomab Therapeutics Ltd盘中异动 股价大涨6.44%报1.32美元
自选股智能写手 · 06-05
Chemomab Therapeutics Ltd盘中异动 股价大涨6.44%报1.32美元
Chemomab Therapeutics Ltd盘中异动 早盘快速上涨7.38%报1.31美元
自选股智能写手 · 06-04
Chemomab Therapeutics Ltd盘中异动 早盘快速上涨7.38%报1.31美元
Chemomab Therapeutics Ltd盘中异动 早盘股价大涨5.62%
自选股智能写手 · 06-03
Chemomab Therapeutics Ltd盘中异动 早盘股价大涨5.62%
Chemomab Therapeutics Ltd盘中异动 早盘大幅下挫5.29%
自选股智能写手 · 05-31
Chemomab Therapeutics Ltd盘中异动 早盘大幅下挫5.29%
Chemomab Therapeutics Ltd盘中异动 股价大涨6.72%
自选股智能写手 · 05-30
Chemomab Therapeutics Ltd盘中异动 股价大涨6.72%
Chemomab Therapeutics Ltd盘中异动 早盘快速拉升5.74%报0.920美元
自选股智能写手 · 05-28
Chemomab Therapeutics Ltd盘中异动 早盘快速拉升5.74%报0.920美元
Chemomab Therapeutics Ltd2024财年第一财季实现净利润-3.91百万美元,同比增加54.90%
自选股智能写手 · 05-18
Chemomab Therapeutics Ltd2024财年第一财季实现净利润-3.91百万美元,同比增加54.90%
Chemomab Therapeutics Ltd盘中异动 股价大涨6.88%报0.870美元
自选股智能写手 · 05-14
Chemomab Therapeutics Ltd盘中异动 股价大涨6.88%报0.870美元
Chemomab Therapeutics Ltd盘中异动 早盘股价大涨6.14%报0.770美元
自选股智能写手 · 05-09
Chemomab Therapeutics Ltd盘中异动 早盘股价大涨6.14%报0.770美元
Chemomab Therapeutics Ltd盘中异动 早盘快速拉升6.12%报0.905美元
自选股智能写手 · 05-07
Chemomab Therapeutics Ltd盘中异动 早盘快速拉升6.12%报0.905美元
Chemomab Therapeutics Ltd盘中异动 股价大涨12.11%
自选股智能写手 · 05-06
Chemomab Therapeutics Ltd盘中异动 股价大涨12.11%
暂无数据
公司概况
公司名称:
Chemomab Therapeutics Ltd.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Chemomab Therapeutics Ltd.于2011年9月22日根据以色列公司法在以色列注册成立。Chemomab是一家处于临床阶段的生物技术公司,致力于发现和开发针对高度未满足需求的纤维化相关疾病的创新疗法。 基于可溶性蛋白CCL24在促进纤维化和炎症中的独特和关键作用,Chemomab开发了CM-101,这是一种旨在结合和阻断CCL24活性的单克隆抗体。 CM-101具有治疗多种严重且威胁生命的炎性和纤维化疾病的潜力,目前正针对孤儿疾病,原发性硬化性胆管炎(PSC)和系统性硬化症(SSc)进行临床开发。
发行价格:
--
{"stockData":{"symbol":"CMMB","market":"US","secType":"STK","nameCN":"Chemomab Therapeutics Ltd.","latestPrice":0.912499,"timestamp":1719604800000,"preClose":0.971001,"halted":0,"volume":69212,"hourTrading":{"tag":"盘后","latestPrice":0.91,"preClose":0.912499,"latestTime":"16:43 EDT","volume":590,"amount":538.8175,"timestamp":1719607388301},"delay":0,"floatShares":9406410,"shares":14218998,"eps":-1.542021,"marketStatus":"休市中","marketStatusCode":7,"change":-0.058502,"latestTime":"06-28 16:00:00 EDT","open":0.97,"high":1.01,"low":0.9,"amount":64459.412675,"amplitude":0.113285,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.542021,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1719820800000},"adr":0,"listingDate":1549947600000,"adjPreClose":0.971001,"adrRate":20,"preHourTrading":{"tag":"盘前","latestPrice":0.95,"preClose":0.953,"latestTime":"08:29 EDT","volume":18,"amount":17.099999999999998,"timestamp":1719577787909},"postHourTrading":{"tag":"盘后","latestPrice":0.91,"preClose":0.912499,"latestTime":"16:43 EDT","volume":590,"amount":538.8175,"timestamp":1719607388301},"volumeRatio":1.311144274107237},"requestUrl":"/m/hq/s/CMMB/tweets","defaultTab":"tweets","newsList":[{"id":"2446285875","title":"Chemomab Therapeutics Ltd盘中异动 快速上涨6.13%报1.060美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446285875","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446285875?lang=zh_cn&edition=full","pubTime":"2024-06-26 03:44","pubTimestamp":1719344665,"startTime":"0","endTime":"0","summary":"北京时间2024年06月26日03时44分,Chemomab Therapeutics Ltd股票出现异动,股价快速拉升6.13%。Chemomab Therapeutics Ltd股票所在的生物技术行业中,整体涨幅为1.28%。Chemomab Therapeutics Ltd公司简介:Chemomab Therapeutics Ltd 是一家临床阶段的生物科技公司,专注于发现和开发针对具有迫切需求的纤维化相关疾病的治疗方法。CM-101已经显示出有潜力治疗多种严重和危及生命的纤维化和炎症性疾病。该公司正在同时推进三项针对CM-101用于治疗罕见纤维化病症的二期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062603442696816b05&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062603442696816b05&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","CMMB"],"gpt_icon":0},{"id":"2446004929","title":"Chemomab Therapeutics Ltd盘中异动 快速拉升5.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446004929","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446004929?lang=zh_cn&edition=full","pubTime":"2024-06-25 00:48","pubTimestamp":1719247721,"startTime":"0","endTime":"0","summary":"北京时间2024年06月25日00时48分,Chemomab Therapeutics Ltd股票出现异动,股价急速拉升5.38%。Chemomab Therapeutics Ltd股票所在的生物技术行业中,整体涨幅为1.86%。Chemomab Therapeutics Ltd公司简介:Chemomab Therapeutics Ltd 是一家临床阶段的生物科技公司,专注于发现和开发针对具有迫切需求的纤维化相关疾病的治疗方法。该公司正在同时推进三项针对CM-101用于治疗罕见纤维化病症的二期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240625004842941f09cc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240625004842941f09cc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","CMMB"],"gpt_icon":0},{"id":"2444217471","title":"Chemomab Therapeutics Ltd盘中异动 早盘快速下挫5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2444217471","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444217471?lang=zh_cn&edition=full","pubTime":"2024-06-20 21:54","pubTimestamp":1718891680,"startTime":"0","endTime":"0","summary":"北京时间2024年06月20日21时54分,Chemomab Therapeutics Ltd股票出现波动,股价快速跳水5.06%。Chemomab Therapeutics Ltd股票所在的生物技术行业中,整体涨幅为0.13%。Chemomab Therapeutics Ltd公司简介:Chemomab Therapeutics Ltd 是一家临床阶段的生物科技公司,专注于发现和开发针对具有迫切需求的纤维化相关疾病的治疗方法。CM-101已经显示出有潜力治疗多种严重和危及生命的纤维化和炎症性疾病。该公司正在同时推进三项针对CM-101用于治疗罕见纤维化病症的二期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240620215440941efd7a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240620215440941efd7a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CMMB","LENZ","BK4139"],"gpt_icon":0},{"id":"2444438287","title":"Chemomab Therapeutics Ltd盘中异动 快速拉升11.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2444438287","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444438287?lang=zh_cn&edition=full","pubTime":"2024-06-18 21:31","pubTimestamp":1718717513,"startTime":"0","endTime":"0","summary":"北京时间2024年06月18日21时31分,Chemomab Therapeutics Ltd股票出现异动,股价急速上涨11.08%。Chemomab Therapeutics Ltd股票所在的生物技术行业中,整体涨幅为0.13%。Chemomab Therapeutics Ltd公司简介:Chemomab Therapeutics Ltd 是一家临床阶段的生物科技公司,专注于发现和开发针对具有迫切需求的纤维化相关疾病的治疗方法。CM-101已经显示出有潜力治疗多种严重和危及生命的纤维化和炎症性疾病。该公司正在同时推进三项针对CM-101用于治疗罕见纤维化病症的二期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061821315395bdd230&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061821315395bdd230&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","CMMB"],"gpt_icon":0},{"id":"2444216773","title":"Chemomab Therapeutics Ltd盘中异动 早盘股价大跌5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2444216773","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444216773?lang=zh_cn&edition=full","pubTime":"2024-06-17 21:37","pubTimestamp":1718631467,"startTime":"0","endTime":"0","summary":"北京时间2024年06月17日21时37分,Chemomab Therapeutics Ltd股票出现波动,股价急速跳水5.31%。Chemomab Therapeutics Ltd股票所在的生物技术行业中,整体跌幅为0.26%。Chemomab Therapeutics Ltd公司简介:Chemomab Therapeutics Ltd 是一家临床阶段的生物科技公司,专注于发现和开发针对具有迫切需求的纤维化相关疾病的治疗方法。该公司正在同时推进三项针对CM-101用于治疗罕见纤维化病症的二期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240617213748941eef78&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240617213748941eef78&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CMMB","LENZ"],"gpt_icon":0},{"id":"2442055212","title":"Chemomab Therapeutics Ltd盘中异动 股价大涨6.01%报1.060美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2442055212","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442055212?lang=zh_cn&edition=full","pubTime":"2024-06-12 21:36","pubTimestamp":1718199363,"startTime":"0","endTime":"0","summary":"北京时间2024年06月12日21时36分,Chemomab Therapeutics Ltd股票出现异动,股价大幅上涨6.01%。截至发稿,该股报1.060美元/股,成交量1252股,换手率0.01%,振幅6.00%。Chemomab Therapeutics Ltd股票所在的生物技术行业中,整体涨幅为0.26%。Chemomab Therapeutics Ltd公司简介:Chemomab Therapeutics Ltd 是一家临床阶段的生物科技公司,专注于发现和开发针对具有迫切需求的纤维化相关疾病的治疗方法。该公司正在同时推进三项针对CM-101用于治疗罕见纤维化病症的二期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061221360395a8ea49&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061221360395a8ea49&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","CMMB"],"gpt_icon":0},{"id":"2442874311","title":"Chemomab Therapeutics Ltd盘中异动 股价大涨9.03%报1.090美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2442874311","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442874311?lang=zh_cn&edition=full","pubTime":"2024-06-12 00:27","pubTimestamp":1718123224,"startTime":"0","endTime":"0","summary":"北京时间2024年06月12日00时27分,Chemomab Therapeutics Ltd股票出现异动,股价急速上涨9.03%。Chemomab Therapeutics Ltd股票所在的生物技术行业中,整体跌幅为0.66%。Chemomab Therapeutics Ltd公司简介:Chemomab Therapeutics Ltd 是一家临床阶段的生物科技公司,专注于发现和开发针对具有迫切需求的纤维化相关疾病的治疗方法。CM-101已经显示出有潜力治疗多种严重和危及生命的纤维化和炎症性疾病。该公司正在同时推进三项针对CM-101用于治疗罕见纤维化病症的二期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240612002704968136b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240612002704968136b1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CMMB","LENZ","BK4139"],"gpt_icon":0},{"id":"2441697650","title":"Chemomab Therapeutics Ltd盘中异动 早盘股价大跌6.13%报1.07美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2441697650","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441697650?lang=zh_cn&edition=full","pubTime":"2024-06-07 21:31","pubTimestamp":1717767089,"startTime":"0","endTime":"0","summary":"北京时间2024年06月07日21时31分,Chemomab Therapeutics Ltd股票出现异动,股价急速跳水6.13%。Chemomab Therapeutics Ltd股票所在的生物技术行业中,整体跌幅为0.05%。Chemomab Therapeutics Ltd公司简介:Chemomab Therapeutics Ltd 是一家临床阶段的生物科技公司,专注于发现和开发针对具有迫切需求的纤维化相关疾病的治疗方法。CM-101已经显示出有潜力治疗多种严重和危及生命的纤维化和炎症性疾病。该公司正在同时推进三项针对CM-101用于治疗罕见纤维化病症的二期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240607213129959898b6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240607213129959898b6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CMMB","BK4139","LENZ"],"gpt_icon":0},{"id":"2441271726","title":"Chemomab Therapeutics Ltd盘中异动 早盘急速跳水6.20%报1.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2441271726","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441271726?lang=zh_cn&edition=full","pubTime":"2024-06-06 21:42","pubTimestamp":1717681320,"startTime":"0","endTime":"0","summary":"北京时间2024年06月06日21时42分,Chemomab Therapeutics Ltd股票出现异动,股价快速下挫6.20%。Chemomab Therapeutics Ltd股票所在的生物技术行业中,整体涨幅为0.13%。Chemomab Therapeutics Ltd公司简介:Chemomab Therapeutics Ltd 是一家临床阶段的生物科技公司,专注于发现和开发针对具有迫切需求的纤维化相关疾病的治疗方法。CM-101已经显示出有潜力治疗多种严重和危及生命的纤维化和炎症性疾病。该公司正在同时推进三项针对CM-101用于治疗罕见纤维化病症的二期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240606214200aef3d185&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240606214200aef3d185&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","CMMB"],"gpt_icon":0},{"id":"2441272535","title":"Chemomab Therapeutics Ltd盘中异动 股价大涨6.44%报1.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2441272535","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441272535?lang=zh_cn&edition=full","pubTime":"2024-06-05 22:05","pubTimestamp":1717596352,"startTime":"0","endTime":"0","summary":"北京时间2024年06月05日22时05分,Chemomab Therapeutics Ltd股票出现异动,股价快速上涨6.44%。截至发稿,该股报1.32美元/股,成交量1.3866万股,换手率0.10%,振幅3.49%。Chemomab Therapeutics Ltd股票所在的生物技术行业中,整体涨幅为0.53%。Chemomab Therapeutics Ltd公司简介:Chemomab Therapeutics Ltd 是一家临床阶段的生物科技公司,专注于发现和开发针对具有迫切需求的纤维化相关疾病的治疗方法。该公司正在同时推进三项针对CM-101用于治疗罕见纤维化病症的二期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240605220552aef38fe2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240605220552aef38fe2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","CMMB"],"gpt_icon":0},{"id":"2440235604","title":"Chemomab Therapeutics Ltd盘中异动 早盘快速上涨7.38%报1.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2440235604","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440235604?lang=zh_cn&edition=full","pubTime":"2024-06-04 21:34","pubTimestamp":1717508042,"startTime":"0","endTime":"0","summary":"北京时间2024年06月04日21时34分,Chemomab Therapeutics Ltd股票出现异动,股价急速上涨7.38%。Chemomab Therapeutics Ltd股票所在的生物技术行业中,整体跌幅为0.04%。Chemomab Therapeutics Ltd公司简介:Chemomab Therapeutics Ltd 是一家临床阶段的生物科技公司,专注于发现和开发针对具有迫切需求的纤维化相关疾病的治疗方法。CM-101已经显示出有潜力治疗多种严重和危及生命的纤维化和炎症性疾病。该公司正在同时推进三项针对CM-101用于治疗罕见纤维化病症的二期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240604213403af8bee82&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240604213403af8bee82&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","CMMB"],"gpt_icon":0},{"id":"2440493015","title":"Chemomab Therapeutics Ltd盘中异动 早盘股价大涨5.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2440493015","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440493015?lang=zh_cn&edition=full","pubTime":"2024-06-03 21:32","pubTimestamp":1717421524,"startTime":"0","endTime":"0","summary":"北京时间2024年06月03日21时32分,Chemomab Therapeutics Ltd股票出现波动,股价急速上涨5.62%。Chemomab Therapeutics Ltd股票所在的生物技术行业中,整体跌幅为0.29%。Chemomab Therapeutics Ltd公司简介:Chemomab Therapeutics Ltd 是一家临床阶段的生物科技公司,专注于发现和开发针对具有迫切需求的纤维化相关疾病的治疗方法。CM-101已经显示出有潜力治疗多种严重和危及生命的纤维化和炎症性疾病。该公司正在同时推进三项针对CM-101用于治疗罕见纤维化病症的二期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240603213205958a048a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240603213205958a048a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CMMB","BK4139"],"gpt_icon":0},{"id":"2439929029","title":"Chemomab Therapeutics Ltd盘中异动 早盘大幅下挫5.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2439929029","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439929029?lang=zh_cn&edition=full","pubTime":"2024-05-31 21:34","pubTimestamp":1717162446,"startTime":"0","endTime":"0","summary":"北京时间2024年05月31日21时34分,Chemomab Therapeutics Ltd股票出现波动,股价大幅下跌5.29%。Chemomab Therapeutics Ltd股票所在的生物技术行业中,整体涨幅为0.86%。Chemomab Therapeutics Ltd公司简介:Chemomab Therapeutics Ltd 是一家临床阶段的生物科技公司,专注于发现和开发针对具有迫切需求的纤维化相关疾病的治疗方法。该公司正在同时推进三项针对CM-101用于治疗罕见纤维化病症的二期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240531213406941eb7f7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240531213406941eb7f7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","CMMB"],"gpt_icon":0},{"id":"2439507734","title":"Chemomab Therapeutics Ltd盘中异动 股价大涨6.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2439507734","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439507734?lang=zh_cn&edition=full","pubTime":"2024-05-30 03:33","pubTimestamp":1717011208,"startTime":"0","endTime":"0","summary":"北京时间2024年05月30日03时33分,Chemomab Therapeutics Ltd股票出现波动,股价急速拉升6.72%。Chemomab Therapeutics Ltd股票所在的生物技术行业中,整体跌幅为0.85%。Chemomab Therapeutics Ltd公司简介:Chemomab Therapeutics Ltd 是一家临床阶段的生物科技公司,专注于发现和开发针对具有迫切需求的纤维化相关疾病的治疗方法。CM-101已经显示出有潜力治疗多种严重和危及生命的纤维化和炎症性疾病。该公司正在同时推进三项针对CM-101用于治疗罕见纤维化病症的二期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405300333289681090c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405300333289681090c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","CMMB"],"gpt_icon":0},{"id":"2438309386","title":"Chemomab Therapeutics Ltd盘中异动 早盘快速拉升5.74%报0.920美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2438309386","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2438309386?lang=zh_cn&edition=full","pubTime":"2024-05-28 23:12","pubTimestamp":1716909165,"startTime":"0","endTime":"0","summary":"北京时间2024年05月28日23时12分,Chemomab Therapeutics Ltd股票出现异动,股价急速上涨5.74%。截至发稿,该股报0.920美元/股,成交量5.6372万股,换手率0.40%,振幅7.79%。Chemomab Therapeutics Ltd股票所在的生物技术行业中,整体跌幅为1.70%。Chemomab Therapeutics Ltd公司简介:Chemomab Therapeutics Ltd 是一家临床阶段的生物科技公司,专注于发现和开发针对具有迫切需求的纤维化相关疾病的治疗方法。该公司正在同时推进三项针对CM-101用于治疗罕见纤维化病症的二期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024052823124596810454&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024052823124596810454&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","CMMB"],"gpt_icon":0},{"id":"2436461509","title":"Chemomab Therapeutics Ltd2024财年第一财季实现净利润-3.91百万美元,同比增加54.90%","url":"https://stock-news.laohu8.com/highlight/detail?id=2436461509","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2436461509?lang=zh_cn&edition=full","pubTime":"2024-05-18 00:23","pubTimestamp":1715963036,"startTime":"0","endTime":"0","summary":"3月31日,Chemomab Therapeutics Ltd公布财报,公告显示公司2024财年第一财季净利润为-3.91百万美元,同比增加54.90%;其中营业收入为0.00美元,每股基本收益为-0.28美元。从资产负债表来看,Chemomab Therapeutics Ltd总负债4.68百万美元,其中短期债务110000.76美元,资产负债比为3.85,流动比率为3.83。机构评级:截至2024年3月31日,当前有3家机构对Chemomab Therapeutics Ltd目标价做出预测,其中目标均价为5.67美元,其中最低目标价为4.00美元,最高目标价为7.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051800235987750ca2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051800235987750ca2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CMMB","LENZ"],"gpt_icon":0},{"id":"2435543511","title":"Chemomab Therapeutics Ltd盘中异动 股价大涨6.88%报0.870美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2435543511","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435543511?lang=zh_cn&edition=full","pubTime":"2024-05-14 23:48","pubTimestamp":1715701722,"startTime":"0","endTime":"0","summary":"北京时间2024年05月14日23时48分,Chemomab Therapeutics Ltd股票出现异动,股价快速上涨6.88%。截至发稿,该股报0.870美元/股,成交量1.3321万股,换手率0.09%,振幅4.41%。Chemomab Therapeutics Ltd股票所在的生物技术行业中,整体跌幅为0.13%。Chemomab Therapeutics Ltd公司简介:Chemomab Therapeutics Ltd 是一家临床阶段的生物科技公司,专注于发现和开发针对具有迫切需求的纤维化相关疾病的治疗方法。该公司正在同时推进三项针对CM-101用于治疗罕见纤维化病症的二期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405142348437a59dbbd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405142348437a59dbbd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","CMMB"],"gpt_icon":0},{"id":"2434327013","title":"Chemomab Therapeutics Ltd盘中异动 早盘股价大涨6.14%报0.770美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2434327013","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434327013?lang=zh_cn&edition=full","pubTime":"2024-05-09 21:30","pubTimestamp":1715261435,"startTime":"0","endTime":"0","summary":"北京时间2024年05月09日21时30分,Chemomab Therapeutics Ltd股票出现异动,股价大幅上涨6.14%。截至发稿,该股报0.770美元/股,成交量5972股,换手率0.04%,振幅0.00%。Chemomab Therapeutics Ltd股票所在的生物技术行业中,整体跌幅为0.56%。Chemomab Therapeutics Ltd公司简介:Chemomab Therapeutics Ltd 是一家临床阶段的生物科技公司,专注于发现和开发针对具有迫切需求的纤维化相关疾病的治疗方法。该公司正在同时推进三项针对CM-101用于治疗罕见纤维化病症的二期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405092130357a5901f9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405092130357a5901f9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","CMMB"],"gpt_icon":0},{"id":"2433200195","title":"Chemomab Therapeutics Ltd盘中异动 早盘快速拉升6.12%报0.905美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2433200195","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433200195?lang=zh_cn&edition=full","pubTime":"2024-05-07 21:40","pubTimestamp":1715089202,"startTime":"0","endTime":"0","summary":"北京时间2024年05月07日21时40分,Chemomab Therapeutics Ltd股票出现波动,股价大幅上涨6.12%。Chemomab Therapeutics Ltd股票所在的生物技术行业中,整体涨幅为0.53%。Chemomab Therapeutics Ltd公司简介:Chemomab Therapeutics Ltd 是一家临床阶段的生物科技公司,专注于发现和开发针对具有迫切需求的纤维化相关疾病的治疗方法。CM-101已经显示出有潜力治疗多种严重和危及生命的纤维化和炎症性疾病。该公司正在同时推进三项针对CM-101用于治疗罕见纤维化病症的二期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405072140027a588597&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405072140027a588597&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","CMMB"],"gpt_icon":0},{"id":"2433476023","title":"Chemomab Therapeutics Ltd盘中异动 股价大涨12.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2433476023","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433476023?lang=zh_cn&edition=full","pubTime":"2024-05-06 21:32","pubTimestamp":1715002333,"startTime":"0","endTime":"0","summary":"北京时间2024年05月06日21时32分,Chemomab Therapeutics Ltd股票出现波动,股价大幅上涨12.11%。Chemomab Therapeutics Ltd股票所在的生物技术行业中,整体涨幅为0.08%。Chemomab Therapeutics Ltd公司简介:Chemomab Therapeutics Ltd 是一家临床阶段的生物科技公司,专注于发现和开发针对具有迫切需求的纤维化相关疾病的治疗方法。CM-101已经显示出有潜力治疗多种严重和危及生命的纤维化和炎症性疾病。该公司正在同时推进三项针对CM-101用于治疗罕见纤维化病症的二期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050621321387d89fd7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050621321387d89fd7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","CMMB"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.chemomab.com","stockEarnings":[{"period":"1week","weight":-0.0188},{"period":"1month","weight":-0.0395},{"period":"3month","weight":0.1714},{"period":"6month","weight":0.7892},{"period":"1year","weight":-0.2521},{"period":"ytd","weight":0.7892}],"compareEarnings":[{"period":"1week","weight":-0.0005},{"period":"1month","weight":0.0344},{"period":"3month","weight":0.0404},{"period":"6month","weight":0.145},{"period":"1year","weight":0.2422},{"period":"ytd","weight":0.145}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Chemomab Therapeutics Ltd.于2011年9月22日根据以色列公司法在以色列注册成立。Chemomab是一家处于临床阶段的生物技术公司,致力于发现和开发针对高度未满足需求的纤维化相关疾病的创新疗法。 基于可溶性蛋白CCL24在促进纤维化和炎症中的独特和关键作用,Chemomab开发了CM-101,这是一种旨在结合和阻断CCL24活性的单克隆抗体。 CM-101具有治疗多种严重且威胁生命的炎性和纤维化疾病的潜力,目前正针对孤儿疾病,原发性硬化性胆管炎(PSC)和系统性硬化症(SSc)进行临床开发。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.064627},{"month":2,"riseRate":0.4,"avgChangeRate":0.038789},{"month":3,"riseRate":0.5,"avgChangeRate":-0.085415},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.080718},{"month":5,"riseRate":0.5,"avgChangeRate":0.041337},{"month":6,"riseRate":0.5,"avgChangeRate":0.017965},{"month":7,"riseRate":0,"avgChangeRate":-0.191804},{"month":8,"riseRate":0.4,"avgChangeRate":-0.066365},{"month":9,"riseRate":0.2,"avgChangeRate":-0.116689},{"month":10,"riseRate":0.4,"avgChangeRate":-0.064276},{"month":11,"riseRate":0.4,"avgChangeRate":-0.098357},{"month":12,"riseRate":0.4,"avgChangeRate":0.063567}],"exchange":"NASDAQ","name":"Chemomab Therapeutics Ltd.","nameEN":"Chemomab Therapeutics Ltd."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.24.2","shortVersion":"4.24.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Chemomab Therapeutics Ltd.(CMMB)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Chemomab Therapeutics Ltd.(CMMB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Chemomab Therapeutics Ltd.,CMMB,Chemomab Therapeutics Ltd.股票,Chemomab Therapeutics Ltd.股票老虎,Chemomab Therapeutics Ltd.股票老虎国际,Chemomab Therapeutics Ltd.行情,Chemomab Therapeutics Ltd.股票行情,Chemomab Therapeutics Ltd.股价,Chemomab Therapeutics Ltd.股市,Chemomab Therapeutics Ltd.股票价格,Chemomab Therapeutics Ltd.股票交易,Chemomab Therapeutics Ltd.股票购买,Chemomab Therapeutics Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Chemomab Therapeutics Ltd.(CMMB)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Chemomab Therapeutics Ltd.(CMMB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}